EP 1390053 A2 20040225 - HCG FORMULATION
Title (en)
HCG FORMULATION
Title (de)
HCG-FORMULIERUNG
Title (fr)
FORMULATION DE GONADOTROPINE CHORIONIQUE HUMAINE
Publication
Application
Priority
- US 0213269 W 20020425
- US 28593901 P 20010425
Abstract (en)
[origin: WO02085311A2] The invention relates to a pharmaceutical composition comprising a biologically active protein or a peptide formulated in water-in-oil emulsion with or without muramyl peptide. More specifically it relates to a preparation of human chorionic gonadotropin (hCG) and related hormones. Also provides are methods of making the composition; methods of using the same against viral infections, immune disorders, and cancer.
IPC 1-7
IPC 8 full level
A61K 9/107 (2006.01); A61K 9/127 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 38/24 (2006.01); A61K 47/14 (2006.01); A61K 47/34 (2006.01); A61K 47/44 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61K 9/113 (2006.01); A61K 47/00 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 38/24 (2013.01); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61K 9/1075 (2013.01); A61K 9/113 (2013.01); A61K 9/1271 (2013.01)
C-Set (source: EP)
Citation (search report)
See references of WO 02085311A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02085311 A2 20021031; WO 02085311 A3 20030821; AU 2002338436 A1 20021105; CN 1512890 A 20040714; EP 1390053 A2 20040225; JP 2004529147 A 20040924; ZA 200309136 B 20051026
DOCDB simple family (application)
US 0213269 W 20020425; AU 2002338436 A 20020425; CN 02810936 A 20020425; EP 02764353 A 20020425; JP 2002582887 A 20020425; ZA 200309136 A 20031125